Exemestane Prescribing at PARKVIEW SURGERY
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
75
Total Quantity
1,122
NHS Cost
£203
vs National Avg
+130.8%
PARKVIEW SURGERY prescribed 75 items of Exemestane over the last 12 months at a cost of £203 to the NHS. This is 130.8% above the national average prescribing rate. Exemestane is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
11
Jun 2026
9
Jun 2026
4
Jun 2026
5
Jun 2026
5
Jun 2026
4
Jun 2026
6
Jun 2026
5
Jun 2026
4
Jun 2026
10
Jun 2026
4
Jun 2026
8
Prescribing Details
| Total Items | 75 |
|---|---|
| Total Quantity | 1,122 |
| Total NHS Cost | £203 |
| Presentations | 1 different forms |
| vs National Average | +130.8% |
Exemestane Prescribing Comparison
| This practice | 75 items |
|---|---|
| National average per practice | 33 items |
| Difference | +130.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.